Age-Associated white matter lesions: The MRC cognitive function and ageing study

Brain Pathology

Volumn 25, Issue 1, 2015, Pages 35-43

  Wharton, Stephen B ^a   Simpson, Julie E ^a   Brayne, Carol ^b   Ince, Paul G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

aging; blood brain barrier; dementia; small vessel disease; vascular; white matter lesions

Indexed keywords

ACUTE DISEASE; AGING; BLOOD BRAIN BARRIER; CARDIOVASCULAR RISK; CELL DAMAGE; CHRONIC DISEASE; COGNITION; CONFERENCE PAPER; DEMENTIA; DEPRESSION; ENCEPHALITIS; GENE EXPRESSION; GLIA; GLIA CELL; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROARRAY ANALYSIS; MOLECULE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; WHITE MATTER LESION; BRAIN; BRAIN ISCHEMIA; IMMUNOMODULATION; LEUKOENCEPHALOPATHIES; LONGITUDINAL STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; UNITED KINGDOM; WHITE MATTER;

AGING; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; COGNITION; DEMENTIA; ENGLAND; HUMANS; LEUKOENCEPHALOPATHIES; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; NEUROGLIA; NEUROIMMUNOMODULATION; WALES; WHITE MATTER;

EID: 84923370271     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12219     Document Type: Conference Paper

References (96)

1. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H, (1997) Alterations in glia and axons in the brains of Binswangers disease patients. Stroke 28: 1423-1429.
2. Bakker S, de Leeuw F, de Groot C, Hofman A, Koudstaal P, Breteler M, (1999) Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 52: 578-583.
3. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al (1999) White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatr 67: 66-72.
4. Bell R, Winkler E, Singh I, Sagare A, Deane R, Wu Z, et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-615.
5. Boche D, Perry V, Nicoll J, (2013) Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39: 3-18.
6. Boulanger J, Messier C, (2014) From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain. Neuroscience 269: 343-355.
7. Bradl M, Lassmann H, (2010) Oligodendrocytes: biology and pathology. Acta Neuropathol 119: 37-53.
8. Breteler M, Van Swieten J, Bots M, Grobbee D, Claus J, Van Den Hout J, et al (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44: 1246-1252.
9. Brown W, Moody D, Thore C, Anstrom J, Challa V, (2009) Microvascular changes in the white matter in dementia. J Neurol Sci 283: 28-31.
10. Brun A, Englund E, (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253-262.
11. Clerici F, Caracciolo B, Cova I, Fusari I, Maggiore L, Galimberti D, et al (2012) Does vascular burden contribute to the progression of mild cognitive impairment to dementia? Dement Geriatr Cogn Disord 34: 235-243.
12. Cooper-Knock J, Kirby J, Ferraiuolo L, Heath P, Rattray M, Shaw P, (2012) Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol 8: 518-530.
13. Crawford A, Chambers C, Franklin R, (2013) Remyelination: the true regeneration of the central nervous system. J Comp Pathol 149: 242-254.
14. Dallasta L, Pisarov L, Esplen J, Werley J, Moses A, Nelson J, et al (1999) Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915-1927.
15. De Leeuw F-E, De Groot J, Achten E, Oudkerk M, Ramos L, Heijboer R, et al (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatr 70: 9-14.
16. Debette S, Markus H, (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. Br Med J 341: c3666.
17. Del Bigio M, Deck J, Davidson G, (2000) Glial swelling with eosinophilia in human post-mortem brains: a change indicative of plasma extravasation. Acta Neuropathol 100: 688-694.
18. Devine M, Fonseca J, Walker Z, (2013) Do cerebral white matter lesions influence the rate of progression from mild cognitive impairment to dementia? Int Psychogeriatr 25: 120-127.
19. Dutta R, Trapp B, (2012) Gene expression profiling in multiple sclerosis brain. Neurobiol Dis 45: 108-114.
20. Englund E, Brun A, (1990) White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 16: 433-439.
21. Englund E, Brun A, Alling C, (1988) White matter changes in dementia of Alzheimer's type. Brain 111: 1425-1439.
22. Farrall A, Wardlaw J, (2009) Blood brain barrier: ageing and microvascular disease-systematic review and meta-Analysis. Neurobiol Aging 30: 337-352.
23. Fernando M, Ince P, (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226: 13-17.
24. Fernando M, O'Brien J, Perry R, English P, Forster G, McMeekin W, et al (2004) Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30: 385-395.
25. Fernando M, Simpson J, Matthews F, Brayne C, Lewis C, Barber R, et al (2006) White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37: 1391-1398.
26. Firbank M, Minett T, O'Brien J, (2003) Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology 61: 95-954.
27. Funfschilling U, Supplie L, Mahad D, Boretius S, Saab A, Edgar J, et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485: 517-521.
28. Gebril O, Kirby J, Savva G, Brayne C, Ince P, (2011) HFE H63D, C282Y and AGTR1 A1166C polymorphisms and brain white matter lesions in the aging brain. J Neurogenet 25: 7-14.
29. Gebril O, Simpson J, Kirby J, Brayne C, Ince P, (2011) Brain iron dysregulation and the risk of ageing white matter lesions. Neuromolecular Med 13: 289-299.
30. Gobin S, Montagne L, Van Zutphen M, Van Der Valk P, Van Den Elsen P, De Groot C, (2001) Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia 36: 68-77.
31. Halliday M, Pomara N, Sagare A, Mack W, Frangione B, Zlokovic B, (2013) Relationship between cyclophilin A levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein E4 carriers and blood-brain barrier breakdown. JAMA Neurol 70: 1198-1200.
32. Hamm S, Dehouck B, Kraus J, Wolburg-Buchholz K, Wolburg H, Risau W, et al (2004) Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res 315: 157-166.
33. Hayakawa K, Miyamoto N, Seo J, Pham L, Kim K, Lo E, et al (2013) High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. J Neurochem 125: 273-280.
34. Huang Y, Zhang W, Lin L, Feng J, Zhao X, Guo W, et al (2010) Could changes in arterioles impede the perivascular drainage of interstitial fluid from the cerebral white matter in leukoaraiosis? Neuropathol Appl Neurobiol 36: 237-247.
35. Ikram M, Luijendijk H, Vernooij M, Horfman A, Niessen W, van der Lugt A, et al (2010) Vascular brain disease and depression in the elderly. Epidemiology 21: 78-81.
36. Inaba M, White L, Bell C, Chen R, Petrovich H, Launer L, et al (2011) White matter lesions on brain magnetic resonance imaging scan and 5-year cognitive decline: the Honolulu-Asia aging study. J Am Geriatr Soc 59: 1484-1489.
37. Katsumata T, Otori T, Nishiyama Y, Okubo S, Nishiyama Y, Nagayama H, et al (2010) Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischaemic stroke. Neurol Res 32: 743-747.
38. Kee H, Lee J, Na D, Kim S, Cheong H, Moon S, et al (2011) Different associations of periventricular and deep white matter lesions with cognition, neuropsychiatric symptoms, and daily activities in dementia. J Geriatr Psychiatry Neurol 24: 84-90.
39. Kinney H, Back S, (1998) Human oligodendroglial development: relationship to periventricular leukomalacia. Semin Pediatr Neurol 5: 180-189.
40. Kirk J, Plumb J, Mirakhur M, McQuaid S, (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201: 319-327.
41. Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, et al (2002) Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 28: 238-251.
42. Launer L, Berger K, Breteler M, Dufouil C, Fuhrer R, Giampaoli S, et al (2006) Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE). Neuroepidemiology 26: 23-29.
43. Lee S, Kim J, Chung S, Kim B, Ahn K, Lee K, (2011) White matter hyperintensities (WMH) are associated with intracranial atherosclerosis rather than extracranial atherosclerosis. Arch Gerontol Geriatr 53: e129-e132.
44. Lee Y, Morrison B, Li Y, Lengacher S, Farah M, Hoffman P, et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487: 443-448.
45. Leech S, Kirk J, Plumb J, McQuaid S, (2007) Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 33: 86-98.
46. Lipton P, (1999) Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568.
47. Lu J, Moochhala S, Kaur C, Ling E, (2001) Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats. J Neurotrauma 18: 399-408.
48. Lund H, Krakauer M, Skimminge A, Sellebjerg F, Garde E, Siebner H, et al (2013) Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis. PLoS ONE 8: e56375.
49. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P, (2001) Platelet-derived growth factor-α receptor positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 49: 776-785.
50. Matthews F, Brayne C, Lowe J, McKeith I, Wharton S, Ince P, (2009) Epidemiological pathology of dementia: attributable-risks at death in the MRC Cognitive Function and Ageing Study. PLoS Med 6: e1000180.
51. McAleese K, Firbank M, Hunter D, Sun L, Hall R, Neal J, et al (2013) Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathol Appl Neurobiol 39: 485-497.
52. Miyamoto N, Pham L, Hayakawa K, Matsuzaki T, Seo J, Magnain C, et al (2013) Age-related decline in oligodendrogliosis retards white matter repair in mice. Stroke 44: 2573-2578.
53. MRC-CFAS (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357: 169-175.
54. Munoz D, (2006) Leukoaraiosis and ischaemia. Beyond the myth. Stroke 37: 1348-1349.
55. Nag S, Kapadia A, Stewart D, (2011) Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37: 3-23.
56. Ovbiagele B, Saver J, (2006) Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 22: 83-90.
57. Pantoni L, Garcia J, Gutierrez J, (1996) Cerebral white matter is highly vulnerable to ischaemia. Stroke 27: 1641-1647.
58. Parpura V, Heneka M, Montana V, Oliet S, Schousboe A, Haydon P, et al (2012) Glial cells in (patho)physiology. J Neurochem 121: 4-27.
59. Pekny M, Nilsson M, (2005) Astrocyte activation and reactive gliosis. Glia 50: 427-434.
60. Potter G, Doubal F, Jackson C, Sudlow C, Dennis M, Wardlaw J, (2012) Lack of association of white matter lesions with ipsilateral carotid artery stenosis. Cerebrovasc Dis 33: 378-384.
61. Prins N, van Dijk E, den Heijer T, Vermeer S, Jolles J, Koudstaal P, et al (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128: 2034-2041.
62. Raiha I, Tarvonen S, Kurki T, Rajala T, Sourander L, (1993) Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 87: 286-289.
63. Raivich G, Banati R, (2004) Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Rev 46: 261-281.
64. Rosenberg G, (2009) Inflammation and white matter damage in vascular cognitive impairment. Stroke 40 (Suppl. 1): S20-S23.
65. Rossor M, (2006) Is the whole brain periventricular? J Neurol Neurosurg Psychiatr 77: 143-144.
66. Sandoval K, Witt K, (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32: 200-219.
67. Scheltens P, Barkhof F, Leys D, Pruvo J, Nauta J, Vermersch P, et al (1993) A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7-12.
68. Scheltens P, Barkhof F, Leys D, Wolters E, Ravid R, Kamphorst W, (1995) Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45: 883-888.
69. Schwartz M, Butovsky O, Bruck W, Hanisch U-K, (2006) Microglial phenotype: is the commitment reversible? Trends Neurosci 29: 68-74.
70. Shafit-Zagardo B, Kress Y, Zhao M, Lee S, (1999) A novel microtubule-Associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 73: 2531-2537.
71. Sim F, Zhao C, Penderis J, Franklin R, (2002) The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22: 2451-2459.
72. Simpson J, Ince P, Higham C, Gelsthorpe C, Fernando M, Matthews F, et al (2007) Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol 33: 670-683.
73. Simpson J, El-Sayad O, Wharton S, Heath P, Holden H, Fernando M, et al (2009) Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke 40: 369-375.
74. Simpson J, Wharton S, Cooper J, Gelsthorpe C, Baxter L, Forster G, et al (2010) Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neurosci Lett 486: 246-251.
75. Simpson J, Ince P, Shaw P, Heath P, Raman R, Garwood C, et al (2011) Microarray analysis of the astrocyte transcriptome in the ageing brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiol Aging 32: 1795-1807.
76. Simpson JE, Fernando M, Clark L, Ince P, Matthews F, Forster G, et al (2007) White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 33: 410-419.
77. Sjobeck M, Haglund M, Englund E, (2006) White matter mapping in Alzheimer's disease: a neuropathological study. Neurobiol Aging 27: 673-680.
78. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
79. Sofroniew M, Vinters H, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
80. Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, et al (2009) Cerebral white matter lesions, gait, and the risk of incident falls. A prospective population-based study. Stroke 40: 175-180.
81. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, et al (1996) Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 27: 2069-2074.
82. van der Valk P, Amor S, (2009) Preactive lesions in multiple sclerosis. Curr Opinion Neurol 22: 207-213.
83. van der Valk P, De Groot C, (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26: 2-10.
84. van Swieten J, van den Hout J, van Ketel B, Hijdra A, Wokke J, van Gijn J, (1991) Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114: 761-774.
85. Viana-Baptista M, Bugalho P, Jordao C, Ribeiro O, Esperanca-Pina J, Ferro J, (2011) Motor dysfunction correlates with frontal white matter ischemic changes in patients with leukoaraiosis. J Aging Res 2011: 950341.
86. Wardlaw J, (2005) What causes lacunar stroke? J Neurol Neurosurg Psychiatr 76: 617-619.
87. Weiss N, Miller F, Cazaubon S, Couraud P-O, (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788: 842-857.
88. Weller RO, Hawkes CA, Kalaria RN, Werring DJ, Carare RO, (2015) White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol 25: 63-78.
89. Wharton S, Brayne C, Savva G, Matthews F, Forster G, Simpson J, et al (2011) Epidemiological neuropathology: the MRC Cognitive Function and Ageing Study experience. J Alzheimer Dis 25: 359-372.
90. Willams G, Stoeber K, (2012) The cell cycle and cancer. J Pathol 226: 352-364.
91. Williams A, Piaton G, Lubetzki C, (2007) Astrocytes-friends or foes in multiple sclerosis? Glia 55: 1300-1312.
92. Winkler E, Sagare A, Zlokovic B, (2014) The pericyte: a forgotten cell type with important implications for Alzheimer's disease? Brain Pathol 24: 371-386.
93. Zaccai J, Ince P, Brayne C, (2006) Population-based neuropathological studies of dementia: design, methods and areas of investigation-A systematic review. BMC Neurol 6: 2.
94. Zlokovic B, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
95. Zlokovic B, (2013) A gliovascular idea for the white matter repair? J Neurochem 125: 172-174.
96. Al-Mashhadi S, Simpson JE, Heath PR, Dickman M, Forster G, Matthews FE, Brayne C, Ince PG, Wharton SB, (2014) Oxidative glial cell damage associated with white matter lesions in the ageing human brain. Brain Pathol doi: 10.1111/bpa.12216.